Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Orbit Discovery and Endevica Bio Enter Multi-target Collaboration to Advance Development of Cachexia Therapeutics
Orbit Discovery, a leader in the discovery of therapeutic peptide hits, today announced it has […]
CARsgen Announces Collaboration Agreement with Roche to Evaluate AB011 in Combination with PD-L1 Checkpoint Inhibitor to Treat Gastric Cancer
CARsgen Therapeutics, a company focused on innovative therapies for the treatment of hematologic malignancies and […]
MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson's Disease
MedRhythms announced the successful completion of a multi-site feasibility study of MR-005, its investigational asset […]
Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome
Ionis Pharmaceuticals today announced that the United States Food and Drug Administration (FDA) has granted […]
Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors
Qurient, a clinical-stage biotech company based in Korea, has announced that the first patient has […]
Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform, Omni Pro 12
Axion BioSystems today announces the addition of the Omni Pro 12 to the Omni live-cell […]
CHOP Experts Share Cutting-Edge Innovations at Arab Health Exhibition
Showcasing its longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children’s […]
Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology
Oricell Therapeutics, an innovative pharmaceutical company committed to the development of clinical-stage oncology cell therapies, […]
Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Stargardt Disease
Nanoscope Therapeutics, a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced […]
Dupixent® (dupilumab) Approved by European Commission as the First and Only Targeted Medicine Indicated for Eosinophilic Esophagitis
Regeneron Pharmaceuticals and Sanofi today announced that the European Commission (EC) expanded the marketing authorization […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more